Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name ↓	B/G	Ingredients	Dosage	Form	Price
A10BD20	SYNJARDY	B	Empagliflozin - 5mg, Metformin HCl - 1000mg	5mg/1000mg	Tablet, film coated	3,399,653 L.L
A10BD20	SYNJARDY	B	Empagliflozin - 5mg, Metformin HCl - 850mg	5mg/850mg	Tablet, film coated	3,287,711 L.L
A10BD20	SYNJARDY	B	Empagliflozin - 12.5mg, Metformin HCl - 850mg	12.5mg/850mg	Tablet, film coated	3,287,711 L.L
A10BD20	SYNJARDY	B	Empagliflozin - 12.5mg, Metformin HCl - 1000mg	12.5mg/1000mg	Tablet, film coated	3,399,653 L.L
A10BD20	SYNJARDY	B	Empagliflozin - 12.5mg, Metformin HCl - 1000mg	12.5mg/1000mg	Tablet, film coated	3,399,653 L.L
J07AL02	SYNFLORIX	B	Polysaccharide from each of 10 capsular types of pneumococcus (conjugated to carrier proteins) adsorbed onto aluminium phosphate - 1mcg/0.5ml, Polysaccharide of serotypes 41,2, 18C1,3 and 19F1,4 - 3mcg/0.5ml, 1 adsorbed onto aluminium phosphate - 0.5mg Al3+, 2 conjugated to protein D (derived from NTHi) carrier protein - ~ 13mcg, 3 conjugated to tetanos toxoid carrier protein - ~ 8mcg, 4 conjugated to diphteria toxoid carrier protein - ~ 5mcg		Injectable suspension	4,675,228 L.L
J01DH51	SYNERGIC	G	Imipenem - 500mg, Cilastatin - 500mg		Injectable powder	1,142,266 L.L
J06BD01	SYNAGIS	BioTech	Palivizumab - 50mg/0.5ml	50mg/0.5ml	Injectable solution	38,316,693 L.L
J06BD01	SYNAGIS	BioTech	Palivizumab - 100mg/ml	100mg/ml	Injectable solution	57,429,464 L.L
N04BB01	SYMMETREL	B	Amantadine - 100mg	100mg	Capsule	568,253 L.L
R03AK07	SYMBICORT TURBUHALER	B	Formoterol fumarate dihydrate - 4.5mcg/inhalation, Budesonide - 160mcg/inhalation		Inhalation powder	1,689,210 L.L
R03AK07	SYMBICORT	B	Formoterol fumarate dihydrate - 9mcg/Inhalation, Budesonide - 320mcg/Inhalation		Inhalation powder	3,378,420 L.L
R03AK07	SYMBICORT	B	Formoterol fumarate dihydrate - 4.5mcg/Inhalation, Budesonide - 160mcg/Inhalation		Inhalation powder	3,378,420 L.L
L01EX01	SUTENT	B	Sunitinib maleate - 50mg	50mg	Capsule	L.L
L01EX01	SUTENT	B	Sunitinib maleate - 12.5mg	12.5mg	Capsule	L.L
L01EX01	SUTENT	B	Sunitinib maleate - 50mg	50mg	Capsule	197,706,574 L.L
L01EX01	SUTENT	B	Sunitinib maleate - 25mg	25mg	Capsule	98,852,769 L.L
L01EX01	SUTENT	B	Sunitinib maleate - 12.5mg	12.5mg	Capsule	54,006,801 L.L
R07AA01	SURVANTA	B	Colfosceril palmitate - 200mg/8ml	200mg/8ml	Suspension	36,957,499 L.L
M01AE11	SURGAM	B	Tiaprofenic acid - 300mg	300mg	Tablet	849,308 L.L
R07AA	SURFACTANTE B RICHET	G	Pulmonary surfactant, bovine - 200mg/8ml	200mg/8ml	Suspension	26,568,472 L.L
J01DD08	SUPRAX 100	B	Cefixime (trihydrate) - 100mg/5ml	100mg/5ml	Powder for suspension	1,166,455 L.L
J01DD08	SUPRAX 100	B	Cefixime (trihydrate) - 100mg/5ml	100mg/5ml	Powder for suspension	1,166,455 L.L
J01DD08	SUPRAX 100	B	Cefixime (trihydrate) - 100mg/5ml	100mg/5ml	Powder for suspension	581,884 L.L
J01DD08	SUPRAX 100	B	Cefixime (trihydrate) - 100mg/5ml	100mg/5ml	Powder for suspension	581,884 L.L
J01DD08	SUPRAX	B	Cefixime (trihydrate) - 400mg	400mg	Capsule	2,053,391 L.L
J01DD08	SUPRAX	B	Cefixime (trihydrate) - 400mg	400mg	Capsule	2,053,391 L.L
J01DD08	SUPRAX	B	Cefixime (trihydrate) - 200mg	200mg	Capsule	1,067,011 L.L
J01DD08	SUPRAX	B	Cefixime (trihydrate) - 200mg	200mg	Capsule	1,067,011 L.L
N01AB07	SUPRANE (DESFLURANE, USP)	B	Desflurane -		Inhalation	9,371,654 L.L

...